IMAGINAB INC has a total of 59 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GENMAB HOLDING B V, BOSTON PHARMACEUTICALS INC and I2 PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Australia | 5 | |
#5 | Canada | 5 | |
#6 | China | 3 | |
#7 | Japan | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Mexico | 3 | |
#10 | Brazil | 2 | |
#11 | Hong Kong | 2 | |
#12 | South Africa | 2 | |
#13 | New Zealand | 1 | |
#14 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Olafsen Tove | 39 |
#2 | Ho David T | 24 |
#3 | Behrenbruch Christian P | 18 |
#4 | Agahi Giti | 16 |
#5 | Gudas Jean | 13 |
#6 | Lipman Arye | 13 |
#7 | Ho David | 10 |
#8 | Olafson Tove | 10 |
#9 | Chan Chio Mui | 9 |
#10 | Satpayev Daulet Kadyl | 9 |
Publication | Filing date | Title |
---|---|---|
WO2020069433A1 | Cd8 imaging constructs and methods of use thereof | |
AU2019282248A1 | Antigen binding constructs to CD4 | |
US2018221507A1 | Extension sequences for diabodies | |
AU2016304764A1 | Antigen binding constructs to target molecules | |
KR20150131208A | Antigen binding constructs to cd8 | |
WO2014164067A1 | Antigen binding constructs to cd30 | |
WO2014158821A1 | Antigen binding constructs to cd70 | |
WO2014137931A1 | Antigen binding constructs to 5t4 | |
EP3786183A2 | Antigen binding constructs to cd3 | |
MX354143B | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use. |